Published in Infect Immun on June 01, 1981
Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates. Virology (2006) 1.66
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates. PLoS Negl Trop Dis (2012) 1.32
Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus). J Immunol Methods (2011) 1.31
Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus. J Virol (2011) 1.26
Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon. Infect Immun (1982) 0.85
Murine resistance to street rabies virus: genetic analysis by testing second-backcross progeny and verification of allelic resistance genes in SJL/J and CBA/J mice. J Virol (1984) 0.84
Involvement of cells of hematopoietic origin in genetically determined resistance of Syrian hamsters to vesicular stomatitis virus. Infect Immun (1981) 0.83
Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV. Cancer Gene Ther (2013) 0.79
Proteins of vesicular stomatitis virus. I. Polyacrylamide gel analysis of viral antigens. J Virol (1969) 5.01
Cell-mediated immunity to vesicular stomatitis virus infections in mice. Exp Cell Biol (1978) 1.57
Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells. J Immunol (1978) 1.37
Variation between strains of hamsters in the lethality of Pichinde virus infections. Infect Immun (1977) 1.28
Cell migration from the thymus to other lymphoid organs in hamsters of different ages. Blood (1968) 1.13
Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection. J Immunol (1980) 1.10
Differences between Syrian hamster strains in natural killer cell activity induced by infection with Pichinde virus. J Immunol (1979) 1.04
Genetic resistance to lethal flavivirus encephalitis. I. Infection of congenic mice with Banzi virus. J Infect Dis (1976) 0.98
Age-related and thymus-dependent rejection of adenovirus 2-transformed cell tumors in the Syrian hamster. Cancer Res (1979) 0.92
Natural cell-mediated cytotoxicity in hamsters. Int J Cancer (1979) 0.88
Rejection of adenovirus 2-transformed cell tumors and immune responsiveness in Syrian hamsters. Cancer Res (1979) 0.85
Susceptibility to fatal Pichinde virus infection in the Syrian hamster. Adv Exp Med Biol (1981) 0.84
THE NORMAL DEVELOPMENT OF THE LYMPHOID MASS IN THE GOLDEN HAMSTER AND ITS RELATIONSHIP TO THE EFFECTS OF THYMECTOMY. Blood (1965) 0.83
Syrian hamsters express polymorphism at an MHC equivalent. Adv Exp Med Biol (1981) 0.81
Proteins of vesicular stomatitis virus. I. Polyacrylamide gel analysis of viral antigens. J Virol (1969) 5.01
The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help. J Exp Med (1978) 4.27
Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol (1980) 4.00
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol (1996) 3.82
Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). Proc Natl Acad Sci U S A (1986) 3.76
Lack of sequence homology among RNAs of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken endogenous RNA-directed DNA polymerase activity. J Virol (1973) 3.62
HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med (1998) 3.61
Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14. Nature (1990) 3.54
Proteins of vesicular stomatitis virus. 3. Intracellular synthesis and extracellular appearance of virus-specific proteins. Virology (1971) 3.17
Proteins of vesicular stomatitis virus. II. Immunological comparisons of viral antigens. J Virol (1970) 2.90
Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees. Nature (1987) 2.82
Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol (1986) 2.65
Reticuloendotheliosis virus nucleic acid sequences in cellular DNA. J Virol (1974) 2.55
Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci (1991) 2.37
Oligonucleotide fingerprints of RNA species obtained from rhabdoviruses belonging to the vesicular stomatitis virus subgroup. J Virol (1977) 2.35
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12
Study of the influence of veterinary medical education on the moral development of veterinary students. J Am Vet Med Assoc (1991) 2.11
Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply. Transplantation (1992) 2.11
The 5' ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J Virol (1995) 2.10
Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol (1990) 2.10
Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. Vet Immunol Immunopathol (1989) 2.09
Clarifying the relationship of veterinary medical education and moral development. J Am Vet Med Assoc (1996) 2.08
Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol (1993) 2.02
Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci (1996) 2.01
Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J Exp Med (1983) 1.94
Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J Virol (1993) 1.88
Ribosomal DNA sequences of Encephalitozoon hellem and Encephalitozoon cuniculi: species identification and phylogenetic construction. J Eukaryot Microbiol (1993) 1.86
A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology (1993) 1.83
Thy-1 antigen-bearing dendritic cells populate murine epidermis. J Invest Dermatol (1983) 1.76
The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III. Ann Intern Med (1985) 1.71
Homotypic and heterotypic interference by defective particles of vesicular stomatitis virus. Nature (1970) 1.71
Encephalitozoonosis (nosematosis) and toxoplasmosis. Am J Pathol (1971) 1.70
Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells. J Immunol (1986) 1.67
Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation. J Immunol (1977) 1.65
Establishment, viral susceptibility and biological characteristics of a swine kidney cell line SK-6. Res Vet Sci (1972) 1.64
Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med (1981) 1.63
Identification and characterization of three Encephalitozoon cuniculi strains. Parasitology (1995) 1.61
Immune response to immunization via the anterior chamber of the eye. II. An analysis of F1 lymphocyte-induced immune deviation. J Immunol (1978) 1.59
TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. J Immunol (1998) 1.59
A distinct African lentivirus from Sykes' monkeys. J Virol (1993) 1.58
Small subunit ribosomal DNA phylogeny of various microsporidia with emphasis on AIDS related forms. J Eukaryot Microbiol (1995) 1.54
Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol (1983) 1.54
Graft-versus-Host reactions: a review. Adv Immunol (1976) 1.53
cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha. J Immunol (1992) 1.50
Endogenous RNA-directed DNA polymerase activity in uninfected chicken embryos. Proc Natl Acad Sci U S A (1972) 1.49
Detection of microsporidia by indirect immunofluorescence antibody test using polyclonal and monoclonal antibodies. J Clin Microbiol (1994) 1.48
Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis. J Invest Dermatol (1991) 1.48
Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site. J Immunol (1992) 1.47
Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res (1992) 1.47
Structural characterization of virion proteins and genomic RNA of human parainfluenza virus 3. J Virol (1984) 1.46
Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells. Virology (1990) 1.45
Syrian hamsters express diverse MHC class I gene products. J Immunol (1990) 1.44
Light-induced migration of retinal microglia into the subretinal space. Invest Ophthalmol Vis Sci (2001) 1.44
The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. Virology (1991) 1.43
Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J Immunol (1991) 1.43
Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur J Immunol (1992) 1.41
Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol (1991) 1.39
Components of saliva inactivate human immunodeficiency virus. Lancet (1986) 1.39
Natural and perturbed distributions of Langerhans cells: responses to ultraviolet light, heterotopic skin grafting, and dinitrofluorobenzene sensitization. J Invest Dermatol (1980) 1.39
Vaginal transmission of human immunodeficiency virus (HIV) to a chimpanzee. J Infect Dis (1986) 1.38
Corneal allografts fail to express Ia antigens. Nature (1979) 1.38
Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells. J Immunol (1985) 1.38
Isolation from African Sykes' monkeys (Cercopithecus mitis) of a lentivirus related to human and simian immunodeficiency viruses. J Virol (1991) 1.38
Microsporidiosis in mammals. Microbes Infect (2000) 1.37
Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg Immunol (1993) 1.36
Antigenuria in St. Louis encephalitis. Am J Trop Med Hyg (1980) 1.34
FACS purification of bone marrow-derived epidermal populations in mice: Langerhans cells and Thy-1+ dendritic cells. J Invest Dermatol (1985) 1.34
Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. Virology (1991) 1.33
Genetic basis of the effects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the Tnfa and Lps loci governs susceptibility. Immunogenetics (1990) 1.32
SIV from stump-tailed macaques: molecular characterization of a highly transmissible primate lentivirus. Virology (1992) 1.29
Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur J Immunol (1992) 1.29
Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice. Invest Ophthalmol Vis Sci (1981) 1.28
Control of expression, glycosylation, and secretion of HIV-1 gp120 by homologous and heterologous signal sequences. Virology (1994) 1.27
Neonatally tolerant mice fail to react against virus-infected tolerated cells. Nature (1977) 1.27
Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. Transpl Immunol (1996) 1.26
Immune regulation and the eye: a dangerous compromise. FASEB J (1987) 1.25
Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol (1993) 1.25
Endogenous RNA-directed DNA polymerase activity in virions of RNA tumor viruses and in a fraction from normal chicken cells. Methods Enzymol (1974) 1.25
IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis. Invest Ophthalmol Vis Sci (2000) 1.25
Studies on the generation of vesicular stomatitis virus (indiana serotype) defective interfering particles. Virology (1978) 1.24
Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol (1994) 1.24
Wild-type isopropylmalate isomerase in Salmonella typhimurium is composed of two different subunits. J Bacteriol (1981) 1.24
Lymphocyte traffic, T-cell malignancies and the skin. J Invest Dermatol (1978) 1.23
Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells. J Immunol (1990) 1.23
Biology of microsporidian species infecting mammals. Adv Parasitol (1998) 1.22
Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation (1997) 1.21
Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens. J Exp Med (1980) 1.21
Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus. Invest Ophthalmol Vis Sci (1984) 1.19
Role of antibody and complement in the control of Encephalitozoon cuniculi infections by rabbit macrophages. Infect Immun (1980) 1.19
Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol (2001) 1.19
Induction of protective cytotoxic T cells with viral proteins. Eur J Immunol (1994) 1.19
Ultraviolet B light-induced alterations in epidermal Langerhans cells are mediated in part by tumor necrosis factor-alpha. Photodermatol Photoimmunol Photomed (1990) 1.18
Pathogenesis of rotavirus infection in mice. Infect Immun (1982) 1.18
Fine structure of Encephalitozoon cuniculi from rabbits, mice and hamsters. J Protozool (1975) 1.18
Glycosylation is not required for the fusion activity of the G protein of vesicular stomatitis virus in insect cells. Virology (1989) 1.17
Nucleotide sequence analysis of the S genomic segment of Prospect Hill virus: comparison with the prototype Hantavirus. Virology (1990) 1.17
Nosema cuiculi: in vitro isolation. Science (1969) 1.17